Cannabis Law Report

JANUARY 11, 2019

Questions continue to be raised, however, about the legality of one of the country’s most popular hemp products, hemp-derived cannabidiol (CBD). federal law protects the retail sale of hemp-derived CBD. . Our analysis follows: Hemp-derived CBD is no longer a controlled substance under federal law.

Hemp 49

Hemp CBD Law Seed-To-Sale 49

The Cannigma

JULY 1, 2022

What if most of it is not based on the level of scientific certainty that cannabis marketing teams and media outlets would have us believe? Because of this variability in the plant, and because of a lack of standard methods–like chemical analyses of cannabinoids or terpenes–has led to inconsistent scientific results. Types of Research.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. E-commerce sales of CBD in the U.S. Consumers spent roughly $31.3

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

SEPTEMBER 24, 2019

Sativex is a cannabis-based medicine that contains THC and CBD and is licensed in the UK for people with multiple sclerosis. “CBD was not recommended by NICE for prescription on the NHS. Cannabidiol oral solution contains highly purified, plant-derived cannabidiol (CBD), a cannabinoid lacking the “high” associated with cannabis.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Cannabis Law Report

JULY 23, 2019

This is particularly the case for cannabis and cannabidiol (CBD) products. Thurston v Koi CBD, LLC. Koi CBD, LLC is a cannabis company based in California. Bianca Thurston, from Pennsylvania, purchased Koi’s CBD products in a local store. Marketing and Advertising Cannabis/CBD Products – Maryland Example.

Law 40

Law Clinical Trials CBD Edibles 40

Cannabis Law Report

JANUARY 4, 2022

Food and Drug Administration (FDA) of the Investigational New Drug (IND) application for the clinical trial evaluating Nantheia™ ATL5, an investigational drug using cannabidiol (CBD) in ANANDA’s proprietary delivery technology as an Adjunctive Treatment for Opioid Use Disorder.

Clinical Trials 52

Clinical Trials Treatment Research and Development Media 52

Cannabis Law Report

SEPTEMBER 29, 2021

Pre-clinical and initial clinical studies show that ANANDA’s Liquid Structure technology (licensed from Lyotropic Delivery Systems (LDS) Ltd. in Jerusalem, Israel) enhances the effectiveness and stability of CBD. Funding for this trial is from the National Institute on Drug Abuse (NIDA). “We ABOUT ANANDA SCIENTIFIC.

Clinical Trials 52

Clinical Trials Medicine Treatment Research and Development 52

Cannabis Law Report

JULY 8, 2021

“Our goal with this study is to enhance the existing treatment’s efficacy through adding CBD to create a new standard of care, potentially improving and extending glioblastoma patients’ quality of life.” Clomiphene will then be added to the regimen for up to 24 patients to rule out toxicity.

Treatment 98

Treatment Clinical Trials CBD Patients 98

Otherside Farms

NOVEMBER 3, 2019

It’s interesting that something like CBD isolate should be enhanced given how much time and energy has been put into developing extraction techniques that even let us arrive at CBD isolate in the first place. But alas, one of the biggest criticisms of CBD isolate is that all it contains is CBD! What we don’t know.

Terpenes 58

Terpenes CBD Research and Development Cannabinoids 58

Cannabis Info

OCTOBER 11, 2019

The researchers are especially hoping the CBD-heavy strain will reduce the most deleterious and troubling effects of dementia. In the Australian clinical study, cannabinoids will be extracted and delivered in a mouth spray, making it easier to be administered to the elderly. How Cannabis Could Help With Dementia.

Treatment 45

Treatment Clinical Trials Cannabinoids Cannabis 45

Alchimia

JANUARY 25, 2022

At the beginning of this new year of 2022, a news story about how cannabis can help fight COVID-19 was picked up by many non-cannabis media. While this research is certainly worth celebrating, the reality behind the message can be easily misunderstood in this age of social media.

Research and Development 98

Research and Development Terpenes CBD Treatment 98

CannaMD

MARCH 8, 2021

CBD treatment dose-dependently diminishes cocaine self-administration and moves the dose-response curve downward. Lastly, by imposing an arbitrary potency cap on just one of marijuana’s 100-plus cannabinoids, H.B. Instead of restricting free speech, the FTC recommends parents practice “media literacy.”. How to learn more.

THC 116

THC Research and Development Treatment Patients 116

The Cannigma

APRIL 8, 2021

Yeah, there are thousands of strains, but those thousands of strains, but those thousands of strains only make let’s say one or two of 60 cannabinoids in abundance. Half of those cannabinoids of plant doesn’t make or three quarters because they’re byproducts. This is by nature of the way we consume cannabinoids.

Medicine 108

Medicine Cannabinoids Cannabis THC 108

Puff Puff Post

SEPTEMBER 16, 2019

This new initiative developed by Santé Cannabis equips physicians with the most up-to-date clinical guidelines, support networks, online and in-person training opportunities so they can prescribe and monitor cannabinoid treatment plans with confidence. Clinical toolkits to help navigate patient assessment and follow-ups.

Programs 108

Programs Research and Development Education Treatment 108

Cannabis Law Report

NOVEMBER 24, 2021

Media representations can offer insights into the nature of the discourse about new medical products and therapies and how ideas and understandings about social phenomena become constructed. This article analyses media representations of medicinal cannabis in Australian medical publications. Background. 2016 ; Sznitman et al.

Research and Development 52

Research and Development Medicine Access Media 52

Puff Puff Post

SEPTEMBER 16, 2019

This new initiative developed by Santé Cannabis equips physicians with the most up-to-date clinical guidelines, support networks, online and in-person training opportunities so they can prescribe and monitor cannabinoid treatment plans with confidence. Clinical toolkits to help navigate patient assessment and follow-ups.

Programs 40

Programs Research and Development Education Treatment 40

Cannabis Law Report

OCTOBER 12, 2021

SAN DIEGO–(BUSINESS WIRE)– #CBD — Radicle Science , a transformative healthtech B-corp validating consumer health products for the first time, secured its initial seed funding in Q4 2020 and surpassed numerous major milestones with accelerating momentum in the first three quarters of 2021.

Clinical Trials 52

Clinical Trials Research and Development Sleep Cannabinoids 52

Cannabis Law Report

DECEMBER 7, 2021

The four-week Institutional Review Board (IRB) approved randomized controlled trial (RCT) of nearly 3,000 participants assigned to different botanical products containing CBD revealed significant improvement across all five health outcomes studied: well-being, quality of life, longer-term pain, feelings of anxiety, and sleep quality.

Clinical Trials 52

Clinical Trials CBD Data Sleep 52

Cannabis Law Report

JUNE 4, 2021

Our proprietary ranking system takes into account: Social reach (social media, blogs, podcasts, publications, etc.). Through his social media outlets, podcast, blog, and interviews, Tim has educated hundreds of millions of people about psychedelics. This list is focused on those who have had the largest impact for 2021. . Followers.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

SpeedWeed

DECEMBER 28, 2018

Bummer: The Cost of Legal CBD. Marinol (synthetic THC) has been available by prescription since 1986, and other synthetic cannabinoid drugs are in the works, but Epidiolex is the first plant-derived pharmaceutical to reach the US market. Which Cannabis Strains Are Highest in CBD, According to Lab Data? ” Sen.

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

NORML

SEPTEMBER 20, 2019

Essentially, the federal government has monopolized cannabis research, and ElSohly’s product, according to some scientists who’ve seen it, is unsuitable for clinical trials. Dr. Sue Sisley: Basically, it comes in these generic batches of either high-THC, high-CBD, or placebo cannabis.

DEA 230

DEA Research and Development Clinical Trials Patients 230